| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Louisiana State University Medical Center, New Orleans, Louisiana 70112-1393
Evidence from pathology and epidemiology studies has been provided for a human model of gastric carcinogenesis with the following sequential stages: chronic gastritis; atrophy; intestinal metaplasia; and dysplasia. The initial stages of gastritis and atrophy have been linked to excessive salt intake and infection with Helicobacter pylori. The intermediate stages have been associated with the ingestion of ascorbic acid and nitrate, determinants of intragastric nitrosation. The final stages have been linked with the supply of β-carotene and with excessive salt intake. Nitrosating agents are candidate carcinogens and could originate in the gastric cavity or in the inflammatory infiltrate.
1 Presented at the 83rd Annual Meeting of the American Association for Cancer Research, May 22, 1992, San Diego, CA. The work on which a substantial portion of this American Cancer Society lecture is based was supported by Grant P01-CA28842 from the National Cancer Institute, NIH, and represents a collaborative effort with other investigators in the United States and Colombia.
Received 9/10/92. Accepted 10/ 7/92.
This article has been cited by other articles:
|
|
 |
|
  R. M. Peek Jr Review: Prevention of gastric cancer: When is treatment of Helicobacter pylori warranted? Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 19 - 31. [Abstract] [PDF]
|
|
|
|
 |
|
 A Larghi, P G Lecca, and G Costamagna High-resolution narrow band imaging endoscopy Gut, July 1, 2008; 57(7): 976 - 986. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gu, L. Yang, Q. Sun, B. Zhou, N. Tang, R. Cong, Y. Zeng, and B. Wang Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Is Associated with an Increased Risk of Gastric Cancer in a Chinese Population Clin. Cancer Res., June 1, 2008; 14(11): 3627 - 3632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chatterjee, E. Sabo, R. Tavares, and M. B. Resnick Inverse Association between Raf Kinase Inhibitory Protein and Signal Transducers and Activators of Transcription 3 Expression in Gastric Adenocarcinoma Patients: Implications for Clinical Outcome Clin. Cancer Res., May 15, 2008; 14(10): 2994 - 3001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Yeh, K. M. Kuntz, M. Ezzati, C. Hur, C. Y. Kong, and S. J. Goldie Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1179 - 1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yanaoka, M. Oka, C. Mukoubayashi, N. Yoshimura, S. Enomoto, M. Iguchi, H. Magari, H. Utsunomiya, H. Tamai, K. Arii, et al. Cancer High-Risk Subjects Identified by Serum Pepsinogen Tests: Outcomes after 10-Year Follow-up in Asymptomatic Middle-Aged Males Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 838 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Argent, R. J. Thomas, F. Aviles-Jimenez, D. P. Letley, M. C. Limb, E. M. El-Omar, and J. C. Atherton Toxigenic Helicobacter pylori Infection Precedes Gastric Hypochlorhydria in Cancer Relatives, and H. pylori Virulence Evolves in These Families Clin. Cancer Res., April 1, 2008; 14(7): 2227 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ohnishi, H. Yuasa, S. Tanaka, H. Sawa, M. Miura, A. Matsui, H. Higashi, M. Musashi, K. Iwabuchi, M. Suzuki, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse PNAS, January 22, 2008; 105(3): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Con, R. Con-Wong, G. R. Con-Chin, V. G. Con-Chin, H. Takeuchi, A. L. Valerin, G. Echandi, F. Mena, F. Brenes, N. Yasuda, et al. Serum Pepsinogen Levels, Helicobacter pylori CagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa Rica Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2631 - 2636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A C de Vries, G A Meijer, C W N Looman, M K Casparie, B E Hansen, N C T van Grieken, and E J Kuipers Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands Gut, December 1, 2007; 56(12): 1665 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ohtani, A. Garcia, A. B. Rogers, Z. Ge, N. S. Taylor, S. Xu, K. Watanabe, R. P. Marini, M. T. Whary, T. C. Wang, et al. Protective role of 17 -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice Carcinogenesis, December 1, 2007; 28(12): 2597 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zavros, M. Waghray, A. Tessier, L. Bai, A. Todisco, D. L. Gumucio, L. C. Samuelson, A. Dlugosz, and J. L. Merchant Reduced Pepsin A Processing of Sonic Hedgehog in Parietal Cells Precedes Gastric Atrophy and Transformation J. Biol. Chem., November 16, 2007; 282(46): 33265 - 33274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Plummer, L.-J. van Doorn, S. Franceschi, B. Kleter, F. Canzian, J. Vivas, G. Lopez, D. Colin, N. Munoz, and I. Kato Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions J Natl Cancer Inst, September 5, 2007; 99(17): 1328 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsukamoto, T. Mizoshita, and M. Tatematsu Animal Models of Stomach Carcinogenesis Toxicol Pathol, August 1, 2007; 35(5): 636 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hansen, S. E. Vollset, M. H Derakhshan, V. Fyfe, K. K Melby, S. Aase, E. Jellum, and K. E L McColl Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status Gut, July 1, 2007; 56(7): 918 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Suzuki, H. Cullings, S. Fujiwara, N. Hattori, S. Matsuura, M. Hakoda, M. Akahoshi, K. Kodama, and E. Tahara Low-Positive Antibody Titer against Helicobacter pylori Cytotoxin-Associated Gene A (CagA) May Predict Future Gastric Cancer Better Than Simple Seropositivity against H. pylori CagA or against H. pylori Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1224 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Loh, V. J. Torres, and T. L. Cover Regulation of Helicobacter pylori cagA Expression in Response to Salt Cancer Res., May 15, 2007; 67(10): 4709 - 4715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, J.-T. Lin, H.-M. Wu, T.-Y. Liu, M.-F. Yen, H.-M. Chiu, H.-P. Wang, M.-S. Wu, and T. Hsiu-Hsi Chen Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 875 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gottschalg, G. B. Scott, P. A. Burns, and D. E.G. Shuker Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer Carcinogenesis, February 1, 2007; 28(2): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Plummer, J. Vivas, G. Lopez, J. C. Bravo, S. Peraza, E. Carillo, E. Cano, D. Castro, O. Andrade, V. Sanchez, et al. Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population J Natl Cancer Inst, January 17, 2007; 99(2): 137 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G M Naylor, T Gotoda, M Dixon, T Shimoda, L Gatta, R Owen, D Tompkins, and A Axon Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients Gut, November 1, 2006; 55(11): 1545 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. S. Algood and T. L. Cover Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses Clin. Microbiol. Rev., October 1, 2006; 19(4): 597 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kamangar, C. Cheng, C. C. Abnet, and C. S. Rabkin Interleukin-1B Polymorphisms and Gastric Cancer Risk--A Meta-analysis. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1920 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Leung, E. K.W. Ng, F. K.L. Chan, W. Y. Chan, K.-f. Chan, A. C.M. Auyeung, C. C.H. Lam, J. Y.W. Lau, and J. J.Y. Sung Effects of Long-term Rofecoxib on Gastric Intestinal Metaplasia: Results of a Randomized Controlled Trial Clin. Cancer Res., August 1, 2006; 12(15): 4766 - 4772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sasazuki, M. Inoue, M. Iwasaki, T. Otani, S. Yamamoto, S. Ikeda, T. Hanaoka, S. Tsugane, and for the Japan Public Health Center Study Group Effect of Helicobacter pylori Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1341 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Weck and H. Brenner Prevalence of Chronic Atrophic Gastritis in Different Parts of the World. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1083 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X-X He, J Yang, Y-W Ding, W Liu, Q-Y Shen, and H H-X Xia Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis Gut, June 1, 2006; 55(6): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ferreira, N. T. Marcos, L. David, J. Nakayama, and C. A. Reis Terminal {alpha}1,4-linked N-acetylglucosamine in Helicobacter pylori-associated Intestinal Metaplasia of the Human Stomach and Gastric Carcinoma Cell Lines. J. Histochem. Cytochem., May 1, 2006; 54(5): 585 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Aoi, H Marusawa, T Sato, T Chiba, and M Maruyama Risk of subsequent development of gastric cancer in patients with previous gastric epithelial neoplasia. Gut, April 1, 2006; 55(4): 588 - 589. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Oishi, Y. Kiyohara, M. Kubo, K. Tanaka, Y. Tanizaki, T. Ninomiya, Y. Doi, K. Shikata, K. Yonemoto, T. Shirota, et al. The Serum Pepsinogen Test as a Predictor of Gastric Cancer: The Hisayama Study Am. J. Epidemiol., April 1, 2006; 163(7): 629 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Cunningham, F. Kamangar, M. P. Kim, S. Hammoud, R. Haque, C. A. Iacobuzio-Donahue, A. Maitra, R. Ashfaq, S. Hustinx, R. E. Heitmiller, et al. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 281 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E M El-Omar Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection Gut, February 1, 2006; 55(2): 144 - 146. [Full Text] [PDF]
|
|
|
|
|
|
W. K. Leung, E. K.W. Ng, W. Y. Chan, A. C.M. Auyeung, K.-f. Chan, C. C.H. Lam, F. K.L. Chan, J. Y.W. Lau, and J. J.Y. Sung Risk Factors Associated with the Development of Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2982 - 2986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Rogers, N. S. Taylor, M. T. Whary, E. D. Stefanich, T. C. Wang, and J. G. Fox Helicobacter pylori but not High Salt Induces Gastric Intraepithelial Neoplasia in B6129 Mice Cancer Res., December 1, 2005; 65(23): 10709 - 10715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Goto, T. Ando, H. Goto, and N. Hamajima No Association Between EGF Gene Polymorphism and Gastric Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2454 - 2456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fan, J. Li, B. Dong, and X. Huang Expression of Cdx2 and Hepatocyte Antigen in Gastric Carcinoma: Correlation with Histologic Type and Implications for Prognosis Clin. Cancer Res., September 1, 2005; 11(17): 6162 - 6170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Wu, C.-J. Chen, and J.-T. Lin Host-Environment Interactions: Their Impact on Progression from Gastric Inflammation to Carcinogenesis and on Development of New Approaches to Prevent and Treat Gastric Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1878 - 1882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Chen, C Rocken, J Hoffmann, S Kruger, U Lendeckel, A Rocco, S Pastorekova, P Malfertheiner, and M P A Ebert Expression of carbonic anhydrase 9 at the invasion front of gastric cancers Gut, July 1, 2005; 54(7): 920 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Sarela, N. Scott, C. S. Verbeke, J. I. Wyatt, S. P. L. Dexter, H. M. Sue-Ling, and P. J. Guillou Diagnostic Variation and Outcome for High-Grade Gastric Epithelial Dysplasia Arch Surg, July 1, 2005; 140(7): 644 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Ohyauchi, A Imatani, M Yonechi, N Asano, A Miura, K Iijima, T Koike, H Sekine, S Ohara, and T Shimosegawa The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population Gut, March 1, 2005; 54(3): 330 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rieder, A. J. Tessier, X. T. Qiao, B. Madison, D. L. Gumucio, and J. L. Merchant Helicobacter-induced Intestinal Metaplasia in the Stomach Correlates with Elk-1 and Serum Response Factor Induction of Villin J. Biol. Chem., February 11, 2005; 280(6): 4906 - 4912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Niwa, Y. Ikehara, H. Nakanishi, H. Tanaka, K.-i. Inada, T. Tsukamoto, M. Ichinose, and M. Tatematsu Mixed Gastric- and Intestinal-type Metaplasia Is Formed by Cells with Dual Intestinal and Gastric Differentiation J. Histochem. Cytochem., January 1, 2005; 53(1): 75 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Mutoh, S Sakurai, K Satoh, H Osawa, T Tomiyama, H Kita, T Yoshida, K Tamada, H Yamamoto, N Isoda, et al. Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma Gut, January 1, 2005; 54(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Nam, K.-B. Hahm, S.-Y. Oh, M. Yeo, S.-U. Han, B. Ahn, Y.-B. Kim, J. S. Kang, D. D. Jang, K.-H. Yang, et al. The Selective Cyclooxygenase-2 Inhibitor Nimesulide Prevents Helicobacter pylori-Associated Gastric Cancer Development in a Mouse Model Clin. Cancer Res., December 1, 2004; 10(23): 8105 - 8113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cui, T. J. Koh, D. Chen, C.-M. Zhao, S. Takaishi, G. J. Dockray, A. Varro, A. B. Rogers, J. G. Fox, and T. C. Wang Overexpression of Glycine-Extended Gastrin Inhibits Parietal Cell Loss and Atrophy in the Mouse Stomach Cancer Res., November 15, 2004; 64(22): 8160 - 8166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mandell, A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones Intact Gram-Negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus Bacteria Activate Innate Immunity via Toll-Like Receptor 2 but Not Toll-Like Receptor 4 Infect. Immun., November 1, 2004; 72(11): 6446 - 6454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Yuan, R. K. Ross, Y.-T. Gao, Y.-H. Qu, X.-D. Chu, and M. C. Yu Prediagnostic Levels of Serum Micronutrients in Relation to Risk of Gastric Cancer in Shanghai, China Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1772 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mutoh, S. Sakurai, K. Satoh, K. Tamada, H. Kita, H. Osawa, T. Tomiyama, Y. Sato, H. Yamamoto, N. Isoda, et al. Development of Gastric Carcinoma from Intestinal Metaplasia in Cdx2-transgenic Mice Cancer Res., November 1, 2004; 64(21): 7740 - 7747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-G. Xi, K.-Y. Ding, X.-L. Su, D.-F. Chen, W.-C. You, Y. Shen, and Y. Ke p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions Carcinogenesis, November 1, 2004; 25(11): 2201 - 2206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Mutoh, S Sakurai, K Satoh, H Osawa, Y Hakamata, T Takeuchi, and K Sugano Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice Gut, October 1, 2004; 53(10): 1416 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W J Lee, W Lijinsky, E F Heineman, R S Markin, D D Weisenburger, and M H Ward Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus Occup. Environ. Med., September 1, 2004; 61(9): 743 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W K Leung, S-R Lin, J Y L Ching, K-F To, E K W Ng, F K L Chan, J Y W Lau, and J J Y Sung Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication Gut, September 1, 2004; 53(9): 1244 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Weisburger Dietary Risk Factors for Gastric Carcinoma JAMA, April 7, 2004; 291(13): 1564 - 1564. [Full Text] [PDF]
|
|
|
|
|
|
M. S.P. Ladeira, M. A.M. Rodrigues, D. M.F. Salvadori, D. M.M. Queiroz, and D. V. Freire-Maia DNA Damage in Patients Infected by Helicobacter pylori Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Dinis-Ribeiro, C Lopes, A da Costa-Pereira, M Guilherme, J Barbosa, H Lomba-Viana, R Silva, and L Moreira-Dias A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia J. Clin. Pathol., February 1, 2004; 57(2): 177 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E J Kuipers, G F Nelis, E C Klinkenberg-Knol, P Snel, D Goldfain, J J Kolkman, H P M Festen, J Dent, P Zeitoun, N Havu, et al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial Gut, January 1, 2004; 53(1): 12 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Malekzadeh, M Sotoudeh, M H Derakhshan, J Mikaeli, A Yazdanbod, S Merat, A Yoonessi, M Tavangar, B A. Abedi, R Sotoudehmanesh, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran J. Clin. Pathol., January 1, 2004; 57(1): 37 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-W. Zhang, N. J. Laurence, A. Hollowood, P. Newcomb, M. Moorghen, J. Gupta, R. Feakins, M. J. G. Farthing, D. Alderson, and J. Holly Prognostic Value of TP53 Codon 72 Polymorphism in Advanced Gastric Adenocarcinoma Clin. Cancer Res., January 1, 2004; 10(1): 131 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wang, J. Q. Huang, G. F. Zheng, S. K. Lam, J. Karlberg, and B. C.-Y. Wong Non-steroidal Anti-inflammatory Drug Use and the Risk of Gastric Cancer: A Systematic Review and Meta-analysis J Natl Cancer Inst, December 3, 2003; 95(23): 1784 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z-R Zeng, P-J Hu, S Hu, R-P Pang, M-H Chen, M Ng, and J J Y Sung Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China Gut, December 1, 2003; 52(12): 1684 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Mills, N. Andersson, T. S. Stappenbeck, C. C. M. Chen, and J. I. Gordon Molecular Characterization of Mouse Gastric Zymogenic Cells J. Biol. Chem., November 14, 2003; 278(46): 46138 - 46145. [Abstract] [Full Text] [PDF]
|
|
